Exscientia

Exscientia company information, Employees & Contact Information

Explore related pages

Related company profiles:

Exscientia is now Recursion.

Company Details

Employees
71
Founded
-
Address
Oxford Science Park, The Schrödinger Building,japan
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oxford, Oxfordshire
Looking for a particular Exscientia employee's phone or email?

Exscientia Questions

News

Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline - Fierce Biotech

Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline Fierce Biotech

Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine - Genetic Engineering and Biotechnology News

Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine Genetic Engineering and Biotechnology News

Exscientia confirms £500 million merger with Recursion - insider.co.uk

Exscientia confirms £500 million merger with Recursion insider.co.uk

Exscientia outline robot and AI use in drug discovery workflow - Pharmaceutical Technology

Exscientia outline robot and AI use in drug discovery workflow Pharmaceutical Technology

Why this A.I. drug development company just bought an Austrian cancer therapy screening startup - Fortune

Why this A.I. drug development company just bought an Austrian cancer therapy screening startup Fortune

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery - Labiotech.eu

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery Labiotech.eu

Exscientia expands AI-powered drug discovery in Miami - Refresh Miami

Exscientia expands AI-powered drug discovery in Miami Refresh Miami

Meet the company developing precision medicine with AI - Fast Company

Meet the company developing precision medicine with AI Fast Company

Salt Lake biotech giant is about to get a little bigger - The Salt Lake Tribune

Salt Lake biotech giant is about to get a little bigger The Salt Lake Tribune

AI drug discovery companies Recursion and Exscientia to merge - Health Tech World

AI drug discovery companies Recursion and Exscientia to merge Health Tech World

UK's Exscientia, Gates Foundation partner to develop variant-resistant COVID-19 drugs - Reuters

UK's Exscientia, Gates Foundation partner to develop variant-resistant COVID-19 drugs Reuters

Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery - Business Wire

Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery Business Wire

US-based Recursion to merge with UK rival Exscientia to create an AI-powered drug discovery giant - Silicon Canals

US-based Recursion to merge with UK rival Exscientia to create an AI-powered drug discovery giant Silicon Canals

Can Exscientia Stock Win the AI Drug Discovery Race? - Nanalyze

Can Exscientia Stock Win the AI Drug Discovery Race? Nanalyze

TIME100 AI 2023: Andrew Hopkins - Time Magazine

TIME100 AI 2023: Andrew Hopkins Time Magazine

Recursion and Exscientia, two leaders in the AI drug - GlobeNewswire

Recursion and Exscientia, two leaders in the AI drug GlobeNewswire

Recursion to Acquire Exscientia, Combining AI Drug Pioneers - Genetic Engineering and Biotechnology News

Recursion to Acquire Exscientia, Combining AI Drug Pioneers Genetic Engineering and Biotechnology News

Biotech firm Recursion to buy smaller peer Exscientia for $688 million - Reuters

Biotech firm Recursion to buy smaller peer Exscientia for $688 million Reuters

Exscientia fires CEO Andrew Hopkins over 'inappropriate' relationships with 2 employees - Fierce Biotech

Exscientia fires CEO Andrew Hopkins over 'inappropriate' relationships with 2 employees Fierce Biotech

Pipeline Pruning: Exscientia Cuts Programs to Sharpen Precision Oncology Focus - Genetic Engineering and Biotechnology News

Pipeline Pruning: Exscientia Cuts Programs to Sharpen Precision Oncology Focus Genetic Engineering and Biotechnology News

AI is dreaming up drugs that no one has ever seen. Now we’ve got to see if they work. - MIT Technology Review

AI is dreaming up drugs that no one has ever seen. Now we’ve got to see if they work. MIT Technology Review

Mubadala and Others Pledge Big Money for UK-Based AI Drug Discovery Firm - ai-cio.com

Mubadala and Others Pledge Big Money for UK-Based AI Drug Discovery Firm ai-cio.com

Recursion Completes Exscientia Merger, Creates AI Drug Discovery Powerhouse with $20B+ Pipeline - Stock Titan

Recursion Completes Exscientia Merger, Creates AI Drug Discovery Powerhouse with $20B+ Pipeline Stock Titan

Chutes & Ladders—Exscientia CEO out after 'inappropriate' relationships with 2 staffers - Fierce Biotech

Chutes & Ladders—Exscientia CEO out after 'inappropriate' relationships with 2 staffers Fierce Biotech

Recursion and Exscientia: The Groundbreaking Merger Shaping AI-Driven Drug Discovery (EXAI, RXRX) - tradingcalendar.com

Recursion and Exscientia: The Groundbreaking Merger Shaping AI-Driven Drug Discovery (EXAI, RXRX) tradingcalendar.com

Andrew Hopkins of Exscientia: the man using AI to cure disease | Pharmaceuticals industry - The Guardian

Andrew Hopkins of Exscientia: the man using AI to cure disease | Pharmaceuticals industry The Guardian

UK medtech company Exscientia raises $60 million to apply AI to drug discovery - Tech.eu

UK medtech company Exscientia raises $60 million to apply AI to drug discovery Tech.eu

Exscientia is the Sniper of the AI Drug Discovery Industry - TradingView

Exscientia is the Sniper of the AI Drug Discovery Industry TradingView

Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery - Business Wire

Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery Business Wire

Is AI the future of medicine? - Pf Media

Is AI the future of medicine? Pf Media

Celgene partners with AI drug discovery startup to make drug trials shorter - verdict.co.uk

Celgene partners with AI drug discovery startup to make drug trials shorter verdict.co.uk

Major deal for AI drug discovery firm Exscientia - BBC

Major deal for AI drug discovery firm Exscientia BBC

Exscientia PLC Sponsored ADR (EXAI) Upgraded to Buy: Here's Why - Yahoo Life UK

Exscientia PLC Sponsored ADR (EXAI) Upgraded to Buy: Here's Why Yahoo Life UK

Fund management giant BlackRock backs $100m injection into UK drug developer Exscientia - Sky News

Fund management giant BlackRock backs $100m injection into UK drug developer Exscientia Sky News

Exscientia raises $60m Series C - UKTN

Exscientia raises $60m Series C UKTN

AI firm founded in Dundee coffee shop in merger to create $2 billion company - The Courier

AI firm founded in Dundee coffee shop in merger to create $2 billion company The Courier

Artificial intelligence-created medicine to be used on humans for first time - BBC

Artificial intelligence-created medicine to be used on humans for first time BBC

Oxford’s Exscientia sells to US firm Recursion for $688m - Insider Media Ltd

Oxford’s Exscientia sells to US firm Recursion for $688m Insider Media Ltd

Significant expansion of AI firm Exscientia’s headquarters at The Oxford Science Park - UKSPA

Significant expansion of AI firm Exscientia’s headquarters at The Oxford Science Park UKSPA

Coronavirus: AI steps up in battle against Covid-19 - BBC

Coronavirus: AI steps up in battle against Covid-19 BBC

Dundee University spin-out Exscientia attracts new investor as it raises $60 million - insider.co.uk

Dundee University spin-out Exscientia attracts new investor as it raises $60 million insider.co.uk

Millionaire uses Artificial Intelligence to develop medicine - BBC

Millionaire uses Artificial Intelligence to develop medicine BBC

Oxford drug company sacks chief executive over ‘inappropriate’ relationships with staff - The Telegraph

Oxford drug company sacks chief executive over ‘inappropriate’ relationships with staff The Telegraph

Multi-millionaire founder of Dundee firm sacked due to ‘inappropriate’ staff relationships - The Courier

Multi-millionaire founder of Dundee firm sacked due to ‘inappropriate’ staff relationships The Courier

Dundee firm Exscientia faces legal action following dismissal of founder Andrew Hopkins - The Courier

Dundee firm Exscientia faces legal action following dismissal of founder Andrew Hopkins The Courier

Dundee University made £40m windfall thanks to artificial intelligence company - The Courier

Dundee University made £40m windfall thanks to artificial intelligence company The Courier

Dr David McBeth: How Dundee outshines the rest of the UK - Scottish Financial News

Dr David McBeth: How Dundee outshines the rest of the UK Scottish Financial News

The man from a Welsh council estate now worth £400m thanks to an idea he had on his walk home - Wales Online

The man from a Welsh council estate now worth £400m thanks to an idea he had on his walk home Wales Online

Ideas man went from council estate to a £400m fortune - Yorkshire Live

Ideas man went from council estate to a £400m fortune Yorkshire Live

Top Exscientia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant